Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An oncolytic virus that kills cancer cells and triggers immune responses against tumors shows promise for children with brain cancer.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
Mixed-size DNA fragments in a blood sample may predict residual cancer as well as MRI scans.
After a median follow-up of 13 months, four of the five patients had ongoing complete remission.
Higher rates of anxiety and depression are associated with higher mortality risk among women with ovarian cancer.
Men with a high genetic risk of prostate cancer can reduce their risk of developing a lethal form of the disease by healthy living.
Colorectal cancer in people under 50 has risen dramatically in recent decades.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.